• Palatin Technologies Inc., of Cranbury, N.J., added Alan W. Dunton to its board.

• PharmacoFore Inc., of San Carlos, Calif., appointed Joseph Stauffer chief medical officer and vice president of corporate strategy and named Narinder Banait vice president of intellectual property.

• PharmAthene Inc., of Annapolis, Md., elected Mitchel Sayare chairman.

• Portola Pharmaceuticals Inc., of South San Francisco, added Michael M. Kitt as senior vice president and chief medical officer.

• Pozen Inc., of Chapel Hill, N.C., formed a digital advisory board that includes Raj Amin, John Bax, Bonin Bough, Marc Monseau, Daniel Palestrant and Meredith Ressi. The comapny also appointed Tomas S. Bocanegra executive vice president of development.

• Prime Therapeutics, of St. Paul, Minn., added Michael Showalter as chief marketing officer.

• ProtAffin AG, of Graz, Austria, appointed Frank Walsh chairman and named Tim Edwards to the board.

• Provectus Pharmaceuticals Inc., of Knoxville, Tenn., added Stuart Fuchs to its corporate advisory board. It also appointed Alfred E. Smith IV to its board.